About Us
Medical Blog
  • FDA Establishes Patient Engagement Advisory Committee

    The FDA recently announced establishment of the Patient Engagement Advisory Committee (PEAC).  According to a notice published by the FDA, the PEAC will advise the Commissioner of the FDA, presently Dr. Stephen Ostroff, M.D., "on complex issues relating to medical devices, regulation of devices, and their use by patients."  In an FDA Voice blog post, Nina L. Hunter, Ph.D., and Robert M. Cali ...
  • TransEnterix Acquires ALF-X for $99.8 Million

    Research Triangle Park, North Carolina-based TransEnterix, Inc. announced today that it has acquired the surgical robotics division of SOFAR S.p.A., an Italian health care company. According to the announcement, the deal is a cash and stock transaction with a total consideration of $99.8 million. According to its website, SOFAR manufactures medicines, nutraceuticals, and medical devices, specia ...
  • Cantel Acquires Medical Innovations for $79.5 Million

    Cantel Medical Corp. has acquired medical device business Medical Innovations Group Holdings Ltd. for $79.5 million, according to press releases. According to its website, Cantel Medical is a global company dedicated to delivering infection prevention and control products and services for patients, caregivers, and other healthcare providers. Cantel's website states that its products include ...
  • Oct


    TCT 2015 – Transcatheter Cardiovascular Therapeutics

    October 12 - 16, 2015

    San Francisco, CA

    Transcatheter Cardiovascular Therapeutics (TCT) is the world’s largest educational meeting specializing in interventional cardiovascular medicine. For over 25 years, TCT has been the center of cutting-edge educational content. TCT showcases the latest advances in current therapies and clinical research. Our longstanding commitment to lifesaving innovation translates into improved patient care.

  • Nov


    Vascular InterVentional Advances (VIVA)

    Wynn Hotel

    November 02 - 5, 2015

    Las Vegas, NV

    VIVA is the premier global, multidisciplinary course for vascular intervention and medicine. For the past 11 years, VIVA has defined excellence in professional education by offering attendees an innovative, provocative, and balanced educational experience, enhanced by the use of technology and electronic interaction between participants and faculty experts.